CN1155377C - 抗首过效应的化合物 - Google Patents

抗首过效应的化合物 Download PDF

Info

Publication number
CN1155377C
CN1155377C CNB988090988A CN98809098A CN1155377C CN 1155377 C CN1155377 C CN 1155377C CN B988090988 A CNB988090988 A CN B988090988A CN 98809098 A CN98809098 A CN 98809098A CN 1155377 C CN1155377 C CN 1155377C
Authority
CN
China
Prior art keywords
formula
chemical compound
compound
selectivity
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB988090988A
Other languages
English (en)
Chinese (zh)
Other versions
CN1270519A (zh
Inventor
Jm
J·M·哈里斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioavailability Systems LLC
Original Assignee
Bioavailability Systems LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/997,259 external-priority patent/US6063809A/en
Priority claimed from US09/001,218 external-priority patent/US6124477A/en
Application filed by Bioavailability Systems LLC filed Critical Bioavailability Systems LLC
Publication of CN1270519A publication Critical patent/CN1270519A/zh
Application granted granted Critical
Publication of CN1155377C publication Critical patent/CN1155377C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fats And Perfumes (AREA)
CNB988090988A 1997-08-26 1998-08-26 抗首过效应的化合物 Expired - Fee Related CN1155377C (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US5638297P 1997-08-26 1997-08-26
US60/056,382 1997-08-26
US08/997,259 US6063809A (en) 1997-08-26 1997-12-23 Anti-first-pass effect compounds
US08/997,259 1997-12-23
US09/001,218 1997-12-30
US09/001,218 US6124477A (en) 1996-06-27 1997-12-30 Anti-first-pass effect compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNA2004100339712A Division CN1537856A (zh) 1997-08-26 1998-08-26 抗首过效应的化合物

Publications (2)

Publication Number Publication Date
CN1270519A CN1270519A (zh) 2000-10-18
CN1155377C true CN1155377C (zh) 2004-06-30

Family

ID=27356877

Family Applications (2)

Application Number Title Priority Date Filing Date
CNB988090988A Expired - Fee Related CN1155377C (zh) 1997-08-26 1998-08-26 抗首过效应的化合物
CNA2004100339712A Pending CN1537856A (zh) 1997-08-26 1998-08-26 抗首过效应的化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA2004100339712A Pending CN1537856A (zh) 1997-08-26 1998-08-26 抗首过效应的化合物

Country Status (18)

Country Link
EP (1) EP1019042B1 (enExample)
JP (1) JP2001526177A (enExample)
CN (2) CN1155377C (enExample)
AP (1) AP2000001746A0 (enExample)
AT (1) ATE238786T1 (enExample)
AU (1) AU750224B2 (enExample)
BR (1) BR9812002A (enExample)
CA (1) CA2299503C (enExample)
CZ (1) CZ295411B6 (enExample)
DE (1) DE69814118T2 (enExample)
DK (1) DK1019042T3 (enExample)
ES (1) ES2199457T3 (enExample)
IL (1) IL134408A0 (enExample)
NZ (1) NZ502767A (enExample)
OA (1) OA11398A (enExample)
PT (1) PT1019042E (enExample)
SI (1) SI1019042T1 (enExample)
WO (1) WO1999009976A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1240831A3 (en) * 2001-03-15 2003-06-04 Takasago International Corporation Color fading/discoloration preventive agent
US6752862B2 (en) 2001-03-16 2004-06-22 Takasago International Corporation Color fading/discoloration preventive agent
EP1896075A2 (en) * 2005-06-22 2008-03-12 LifeCycle Pharma A/S Pharmaceutical compositions comprising tacrolimus and a cyp3a4 inhibitor
JP5481746B2 (ja) * 2009-09-28 2014-04-23 公益財団法人東洋食品研究所 フロクマリン類の含有量を低減したイチジクの製造方法
WO2024223797A1 (en) 2023-04-28 2024-10-31 Institut National de la Santé et de la Recherche Médicale Use of cyp3a4 inhibitors for the treatment of hepatitis d virus (hdv) infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2168696B (en) * 1984-12-21 1989-01-11 Boehringer Biochemia Srl Fluoro coumarins as antilymphoedema agents

Also Published As

Publication number Publication date
CZ295411B6 (cs) 2005-08-17
DE69814118T2 (de) 2004-04-01
DK1019042T3 (da) 2003-08-25
PT1019042E (pt) 2003-09-30
CA2299503A1 (en) 1999-03-04
OA11398A (en) 2004-04-14
CN1270519A (zh) 2000-10-18
SI1019042T1 (en) 2003-12-31
ATE238786T1 (de) 2003-05-15
ES2199457T3 (es) 2004-02-16
JP2001526177A (ja) 2001-12-18
EP1019042A1 (en) 2000-07-19
AU750224B2 (en) 2002-07-11
IL134408A0 (en) 2001-04-30
CZ2000695A3 (cs) 2000-08-16
DE69814118D1 (en) 2003-06-05
AP2000001746A0 (en) 2000-03-31
WO1999009976A1 (en) 1999-03-04
NZ502767A (en) 2001-11-30
EP1019042B1 (en) 2003-05-02
CA2299503C (en) 2006-08-22
AU9028898A (en) 1999-03-16
BR9812002A (pt) 2000-09-26
EP1019042A4 (en) 2001-07-11
CN1537856A (zh) 2004-10-20

Similar Documents

Publication Publication Date Title
US7514572B2 (en) Anti-first-pass effect compounds
US7576124B2 (en) Anti-first-pass effect compounds
DK2430017T3 (en) PROCESS FOR THE PREPARATION OF AMORPHOUS silibinin.
WO2021022378A1 (en) Oral formulations of cannabis extracts and methods of making same
US6124477A (en) Anti-first-pass effect compounds
CN1450901A (zh) 应用与乙酰水杨酸联合的可可矢车菊苷配质作为抗血小板疗法
CN1155377C (zh) 抗首过效应的化合物
CN1123340C (zh) 抗过敏剂
CN1863542A (zh) 植物种子提取物及其制备方法
CN1733704A (zh) 甜菜碱水杨酸盐的合成及其生物学和药理学作用
MXPA00001714A (en) Anti-first-pass effect compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040630

Termination date: 20090928